| | | | | | | | | | | | | | | | | | | | | | | |
|
|
|
|
| 2006P-0209
|
| Safety or Efficacy of Diastat (diazepam rectal gel), 5 mg/ml, 10mg/2 ml, 15 mg/3 ml and 20 mg/4 ml
|
|
|
|
|
|
|
|
|
|
|
|
|
| FDA Comment Number :
|
| EC13
|
|
|
|
|
| Submitter :
|
| Mr. Dave Lowe
|
| Date & Time:
|
| 08/02/2006 11:08:46
|
|
|
|
|
| Organization :
|
| Mr. Dave Lowe
|
|
|
|
|
| Category :
|
| Individual Consumer
|
|
|
|
|
| Issue Areas/Comments
|
|
|
|
|
|
| GENERAL
|
|
|
|
|
|
|
|
| GENERAL
|
|
|
|
|
|
|
|
| I oppose the peitition in whole. The current supplement in the Orange Book is inaccurate. I oppose the safety and efficacy of Abilify. One cannot marketing off label (bipolar disorder), and without scientific TE, or RLD's. See PDF of the website and the Orange Book. Misbrand Abilify and withdraw any paper NDA's and Fed Reg determinations that may or may not be approving such legally for BMS.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2006P-0209-EC13-Attach-1.PDF
|
|